NDC 65597-504-28
VANFLYTA 17.7 mg/1
QUIZARTINIB · TABLET, FILM COATED
Vanflyta (quizartinib) is an oral tablet used to treat adults with acute myeloid leukemia that has a specific genetic mutation. It works by blocking certain proteins that help leukemia cells grow.
Key Facts
- Brand Name
- VANFLYTA
- Generic Name
- QUIZARTINIB
- NDC Code (Package)
65597-504-28- NDC Code (Product)
65597-504- Manufacturer
- Daiichi Sankyo Inc.
- Strength
- 17.7 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA216993
- Marketing Start
- 07/20/2023
Recall History
No Recall HistoryView Full Drug Page
VANFLYTA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.